Skip to main content

WPI 3154 (Modafinil 100 mg)

Pill with imprint WPI 3154 is White, Capsule-shape and has been identified as Modafinil 100 mg. It is supplied by Watson Laboratories, Inc.

Modafinil is used in the treatment of narcolepsy; obstructive sleep apnea/hypopnea syndrome; shift work sleep disorder and belongs to the drug class CNS stimulants. Risk cannot be ruled out during pregnancy. Modafinil 100 mg is classified as a Schedule 4 controlled substance under the Controlled Substance Act (CSA).

Images for WPI 3154

Modafinil 100 mg WPI 3154
Modafinil 100 mg WPI 3154
Modafinil 100 mg WPI 3154 Front
Modafinil 100 mg WPI 3154 Back

Modafinil

Imprint
WPI 3154
Strength
100 mg
Color
White
Shape
Capsule-shape
Availability
Prescription only
Drug Class
CNS stimulants
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
4 - Some potential for abuse
Labeler / Supplier
Watson Laboratories, Inc.
Inactive Ingredients
lactose monohydrate, corn starch, crospovidone, croscarmellose sodium, silicon dioxide, magnesium stearate, magnesium silicate

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
00591-3499 (Discontinued) Watson Pharmaceuticals, Inc.
42291-0599 (Discontinued) AvKare, Inc.
00904-6423 (Discontinued) Major Pharmaceuticals

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.